This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Non-Hodgkin's Lymphoma (NHL)
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Zevalin for relapsed or refractory, CD20+, low grade B-cell non-Hodgkin's lymphoma and Mantle cell lymphoma. The objective of this study is to assess safety and efficacy of using Zevalin in clinical practice. This study is also all case investigation of which the enrollment period is five years, and all patients who received Zevalin will be recruited and followed 13 weeks after the administration.

Provided treatments

  • Drug: [90]Y-ibritumomab tiuxetan (Zevalin, BAY86-5128)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01448928. The sponsor of the trial is Spectrum Pharmaceuticals, Inc and it is looking for 400 volunteers for the current phase.
Official trial title:
Drug Use Investigation of Zevalin